JPRN-jRCTs041210062
Recruiting
Phase 2
The clinical utility of botulinum toxin type A for plantar hyperhidrosis
Ohshima Yuichiro0 sites40 target enrollmentSeptember 1, 2021
Conditionsplantar hyperhidrosis
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- plantar hyperhidrosis
- Sponsor
- Ohshima Yuichiro
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who meet the criteria of primary focal hyperhidrosis for plantar; Focal, visible, excessive sweating of at least 6 months duration without apparent cause with at least two of the following characteristics:
- •1\) Age of onset less than 25 years
- •2\) Bilateral and relatively symmetric
- •3\) Cessation of focal sweating during sleep
- •4\) Frequency of at least one episode per week
- •5\) Positive family history
- •6\) Impairs daily activities
Exclusion Criteria
- •Patients who has symptom of irritation ag ainst component of botulinum toxin type A.
- •Preg nant women or women who may be pregnant.
- •Patients with systemic neuromuscular junction dysfunction (myasthenia g ravis, Lambert\-Eaton synd
- •rome, amyotrophic lateral sclerosis and others).
- •Patients who was treated by botulinum toxin type A within 1 year and suspected the presence of neutralizing antibodies.
- •Patients who are using other types of botulinum toxin and muscle relaxants (tubocurarine chloride hydrochloride hydrate, dantrolene sodium hydrate and others).
- •In case a patient conducts other treatments for hyperhidrosis (external or internal medicine), s/he needs to have a washout period for 1 month.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Is neuromodulation with botulinum toxin type A an alternative treatment for chronic anal fissure?Chronic anal fissureDigestive SystemISRCTN90354265Hospital General Nuestra Señora del Prado49
Active, not recruiting
Phase 1
botulinum toxin for the treatment of chronic anal fissureChronic anal fissureTherapeutic area: Not possible to specifyEUCTR2017-001216-11-ESDra. A. Teresa Calderón Duque
Active, not recruiting
Phase 4
To check wrinkle free forehead after injection of Botulinum drug.CTRI/2015/03/005613Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Recruiting
Phase 1
Safety and efficacy of botulinum toxin A (Botox) in patients with trigeminal neuralgiaTrigeminal neuralgiaMedDRA version: 20.0Level: PTClassification code: 10044652Term: Trigeminal neuralgia Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2023-504567-17-00Rigshospitalet80
Completed
Not Applicable
The efficacy and safety of botulinum toxin type B on digital ulcers in patients with systemic sclerosisdigital ulcers in systemic sclerosis patientsJPRN-UMIN000024818Gunma University Hospital10